Parameter | Normal | RA | SLE | SLE repeat |
---|---|---|---|---|
Number of subjects | 30 | 60 | 60 | 37 |
Age (mean [range]; years) | 36.5 (21.2–54.4) | 47.3 (19.1–71.7) | 39.4 (19.4–66.8) | 35.1 (20.4–66.3) |
Sex (female/male; n) | 27/3 | 52/8 | 56/4 | 36/1 |
Race (n) | Â | Â | Â | Â |
Asian | 11 | 5 | 5 | 2 |
Black | 3 | 3 | 6 | 3 |
Hispanic | 13 | 51 | 49 | 32 |
White | 3 | 1 | 0 | 0 |
Prednisone use | Â | Â | Â | Â |
Number of patients | - | 17 | 50 | 31 |
Mean dosage (mg/day) | - | 5.5 | 10.8 | 6.0 |
Dosage range (mg/day) | - | 2.5–10 | 2–30 | 1–30 |
Use of other medications (n) | Â | Â | Â | Â |
Cyclophosphamide | - | 0 | 4 | 2 |
Azathioprine | - | 4 | 27 | 15 |
Mycophenolate mofetil | - | 1 | 9 | 13 |
Methotrexate | - | 42 | 2 | 2 |
Sulfasalazine | - | 17 | 0 | 0 |
Hydroxychloroquine | - | 36 | 53 | 36 |
Leflunomide | - | 0 | 1 | 0 |
Any TNF antagonist | - | 18 | 0 | 0 |